Yesterday’s Executive Order to operationalize the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR™) marks a pivotal milestone in strengthening America’s pharmaceutical supply chain resilience.
Phlow is honored to have originated the SAPIR framework more than five years ago in partnership with @HHSGov and @ASPRgov. Their leadership and dedication to national preparedness have been instrumental in elevating SAPIR to a matter of national policy.
We celebrate this important step toward safeguarding reliable access to essential medicines for all Americans, and we remain committed to working collaboratively across sectors to strengthen the nation’s health security.
Read our full statement: https://t.co/4YrkFmjtmh
Together with the U.S. government, we will ensure preparedness for future national health crises with an integrated, cost-effective, and comprehensive solution that provides reliability, high quality, and supply chain resilience. https://t.co/qgHZCHbrPl
We believe the essential medicines we make at Phlow today, in partnership with USP, will save countless American lives tomorrow. https://t.co/3BmmOWVjtw